Market research
RLT.AU Renergen Limited
AU AUD Energy
Latest close
As of 11 Feb 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 116M
- P/E ratio
- Not available
- Analyst target
- 4.89
- Dividend yield
- Not available
- Beta
- 1.12
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Energy
- Industry
- Oil & Gas E&P
- ISIN
- AU0000046732
- Market cap
- 116M
- P/E ratio
- Not available
- Analyst target
- 4.89
- Dividend yield
- Not available
- Beta
- 1.12
About
About Renergen Limited
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.
Research context
Renergen Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Energy
- Industry
- Oil & Gas E&P
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the RLT.AU discussion.
5 years, 6 months ago
Renergen Limited is currently in a long term uptrend where the price is trading 4.1% above its 200 day moving average.
From a valuation standpoint, the stock is 2751.4% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 1511.1.
Renergen Limited's total revenue sank by 36.8% to $910K since the same quarter in the previous year.
Its net income has increased by 28.0% to $-27M since the same quarter in the previous year.
Finally, its free cash flow grew by 23.7% to $-39M since the same quarter in the previous year.
Based on the above factors, Renergen Limited gets an overall score of 3/5.